期刊文献+

肝素诱导的血小板减少症患者体外循环抗凝管理 被引量:5

Anticoagulation Management in Patients with Heparin-induced Thrombocytopenia Undergoing Extracorporeal Circulation
原文传递
导出
摘要 肝素诱导的血小板减少症患者预后差,病死率高,大大增加了体外循环手术的风险。对其早期诊断和选择一种安全有效的药物替代肝素抗凝是这类患者接受体外循环手术的关键。我们对肝素诱导的血小板减少症发病机制、实验室检查、诊断以及体外循环抗凝管理进行综述。 Patients with heparin-induced thrombocytopenia have a poor prognosis and high mortality,thus surgical risk under extracorporeal circulation increased.Early diagnosis,safe and effective alternative anticoagulation strategy are crucial for these patients to receive extracorporeal circulation surgery.This review focuses on the pathophysiology,laboratory examination,diagnosis and alternative anticoagulation strategy of extracorporeal circulation for patients with heparin-induced thrombocytopenia.
作者 周伯颐 龙村
出处 《中国胸心血管外科临床杂志》 CAS 2012年第5期559-562,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词 肝素诱导的血小板减少症 体外循环 抗凝 Heparin-induced thrombocytopenia Extracorporeal circulation Anticoagulation
  • 相关文献

参考文献33

  • 1Warkentin TE. Clinical presentation of heparin-induced thrombocy- topenia. Semin Hematol, 1998, 35 (4 Suppl 5 ) : 9-16.
  • 2Gurbuz AT, Elliott WG, Zia AA. Heparin-indueed thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines. Eur J Cardiothorac Surg, 2005, 27 ( 1 ) : 138-149.
  • 3Hirsh J, Heddle N, Kelton JG, et al. thrombocytopenia: a critical review 361-369.
  • 4Treatment of heparin-induced Arch Intern Med, 2004, 164: Theodore E, Jo-Arm I, Jane C, et aL Laboratory testing for the anti- bodies that cause heparin-indueed thrombocytopenia: how much do we need ? J Lab Clin Med, 2005, 146: 341-346.
  • 5Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res, 2006, 118(2): 165-176.
  • 6Denys B, Devreese K. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thromboc:openia: An update. Thromb Res, 2009, 124 (5) : 642-643.
  • 7Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest, 2005, 127 (2 Suppl) : 35S-45S.
  • 8Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Confer- ence on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 1263 (Suppl) : 311S-337S.
  • 9Warkentin TE, Sheppard JA, Moore JC, et al. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need ? J Lab Clin Med, 2005, 146 (6): 341-346.
  • 10Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost, 2006, 4 (4) : 759-765.

同被引文献34

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部